Amgen will host a webcast investor call on Monday, March 16, at 1 p.m. PT. Sean E. Harper, M.D., executive vice president of Research and Development at Amgen, along with members of Amgen's clinical development team, will participate in the call to discuss Amgen's cardiovascular program, including Repatha and Corlanor data presented at ACC.15.